Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine for Depression after TBI
NCT02845349Phase 3Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Oct 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of vortioxetine in major depressive disorder (MDD), sponsored by Johns Hopkins University. Planned start Oct 2016; status: withdrawn.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02845349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02845349.